Mechanisms mediating the ability of caffeine to influence MDMA (‘Ecstasy’)‐induced hyperthermia in rats

Authors:

Abstract
Background and purpose: Caffeine exacerbates the hyperthermia associated with an acute exposure to 3,4 methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) in rats. The present study investigated the mechanisms mediating this interaction.Experimental approach: Adult male Sprague‐Dawley rats were treated with caffeine (10 mg·kg−1; i.p.) and MDMA (15 mg·kg−1; i.p.) alone and in combination. Core body temperatures were monitored before and after drug administration.Key results: Central catecholamine depletion blocked MDMA‐induced hyperthermia and its exacerbation by caffeine. Caffeine provoked a hyperthermic response when the catecholamine releaserd‐amphetamine (1 mg·kg−1) was combined with the 5‐HT releaserd‐fenfluramine (5 mg·kg−1) or the non‐selective dopamine receptor agonist apomorphine (1 mg·kg−1) was combined with the 5‐HT2receptor agonist DOI (2 mg·kg−1) but not following either agents alone. Pretreatment with the dopamine D1receptor antagonist Schering (SCH) 23390 (1 mg·kg−1), the 5‐HT2receptor antagonist ketanserin (5 mg·kg−1) or α1‐adreno‐ receptor antagonist prazosin (0.2 mg·kg−1) blocked MDMA‐induced hyperthermia and its exacerbation by caffeine. Co‐administration of a combination of MDMA with the PDE‐4 inhibitor rolipram (0.025 mg·kg−1) and the adenosine A1/2receptor antagonist 9‐chloro‐2‐(2‐furanyl)‐[1,2,4]triazolo[1,5‐C]quinazolin‐5‐amine 15943 (10 mg·kg−1) or the A2Areceptor antagonist SCH 58261 (2 mg·kg−1) but not the A1receptor antagonist DPCPX (10 mg·kg−1) exacerbated MDMA‐induced hyperthermia.Conclusions and implications: A mechanism comprising 5‐HT and catecholamines is proposed to mediate MDMA‐induced hyperthermia. A combination of adenosine A2Areceptor antagonism and PDE inhibition can account for the exacerbation of MDMA‐induced hyperthermia by caffeine.

This publication has 76 references indexed in Scilit: